{"organizations": ["Management and Treatment of Migraine", "Healthcare Products Regulatory Agency", "CTA", "Depomed, Inc.", "Migraine Foundation", "Canaccord Genuity Cardio/Diabetes & Obesity Conference MHRA", "Randers", "Cardio/Diabetes & Obesity Conference", "The American Migraine Foundation Join Forces", "MHRA", "Medical Device Manufacturing", "BioMarin Pharmaceutical Inc."], "uuid": "98de99ebde46500c2f9bd742a2f1e100a310e32d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/AVINTIV-Announces-Price-Increases--North-America-48179-1/", "country": "US", "title": "AVINTIV Announces Price Increases, North America", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "AVINTIV Announces Price Increases, North America", "spam_score": 0.0, "site_type": "news", "published": "2015-09-09T12:16:00.000+03:00", "replies_count": 0, "uuid": "98de99ebde46500c2f9bd742a2f1e100a310e32d"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/AVINTIV-Announces-Price-Increases--North-America-48179-1/", "ord_in_thread": 0, "title": "AVINTIV Announces Price Increases, North America", "locations": ["North America", "Herning", "Mass.", "UK", "SYDNEY", "NOVATO", "Calif.", "Belgium", "Hilleroed", "FRAMINGHAM", "China", "Bispebjerg", "Horsens"], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": ["Doug Godshall"], "text": "  Sept. 9, 2015 While an estimated 36 million ... people speak to a doctor[3] about their headaches. Of ... of Migraine Awareness Week, September 6-12, 2015, Depomed, Inc. ... Migraine Foundation (AMF) to highlight the importance of seeking ... properly diagnose and correctly treat migraine.   Sept 9, 2015 The medical devices industry is ... China,s medical device market reached a scale of ... the challenges faced by China,s medical ... of the high-end medical device field, and financing difficulties for ... of MEDTEC China, said: China,s medical   , Belgium , Sept. 9, 2015 ... today announced interim results from its 4,800-subject retrospective colorectal ... at six collaborating hospitals (Bispebjerg, Herning, Hilleroed, Horsens, Randers ... interim data indicates that VolitionRx,s NuQ Â® blood ... equally well for both for early- and late-stage cancers. ... [ 0 ] Depomed and The American Migraine Foundation Join Forces to Highlight Need for the Proper Diagnosis, Management and Treatment of Migraine [ 0 ] Seek The Story behind China's Medical Device Manufacturing [ 0 ] VolitionRx Demonstrates NuQ(R) Blood Test Detects 81% of Colorectal Cancers and 67% of High Risk Adenomas in Large Double Blinded Clinical Trial ... FRAMINGHAM, Mass. and SYDNEY, Dec. 2, 2010 HeartWare ... a leading innovator of less invasive, miniaturized circulatory support ... failure, today announced that CEO Doug Godshall is scheduled ... Cardio/Diabetes & Obesity Conference on Tuesday, December 7, 2010 ... ... NOVATO, Calif., Dec. 2, 2010 BioMarin Pharmaceutical Inc. (Nasdaq: ... Healthcare Products Regulatory Agency (MHRA) in the UK has completed ... a notice of acceptance for BMN 673 for genetically-defined cancers. ... the first quarter of 2011. \"BMN 673 has ... HeartWare to Present at the Canaccord Genuity Cardio/Diabetes & Obesity Conference MHRA Completes Review of CTA and Issues Notice of Acceptance for BMN 673 for Genetically-Defined Cancers  ", "external_links": [], "published": "2015-09-09T12:16:00.000+03:00", "crawled": "2015-09-10T01:31:25.055+03:00", "highlightTitle": ""}